Structure and function of contractile proteins in human dilated cardiomyopathy

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Dilated cardiomyopathy (DCM) is characterized by reduced systolic left ventricular function.
• The underlying pathogenesis, particularly the role of contractile proteins, remains unclear.

Purpose of the Study:

• To investigate the function and structure of left ventricular myofibrils in DCM.
• To determine if contractile protein alterations contribute to reduced myocardial contractility in DCM.

Main Methods:

• Comparison of myofibrils from hearts of DCM patients and healthy controls.
• Analysis of myosin and actin content.
• Two-dimensional electrophoresis and immunoblotting for polypeptide composition.
• Assessment of myofibrillar adenosine triphosphatase (ATPase) activities.
• Structural analysis of purified myosin.

Main Results:

• Slightly reduced myosin and actin content in DCM hearts.
• No significant differences in myofibrillar polypeptide composition, including Z-line and endosarcomeric lattice proteins.
• Identical M-line-bound creatine kinase levels.
• Unaltered basal and maximal myofibrillar ATPase activities.
• Identical structural and functional properties of purified myosin between DCM and control groups.

Conclusions:

• Structural alterations or functional defects of myofibrils do not appear to be the primary cause of reduced myocardial contractility in dilated cardiomyopathy.
• The pathogenesis of reduced systolic function in DCM likely involves other mechanisms beyond contractile protein abnormalities.